Research Article
Strategy for Calculating Magnesium Sulfate Dose in Obese Patients: A Randomized Blinded Trial
Table 2
Mean and standard deviation of blood magnesium concentration in three groups over time (mg dL−1).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOG, Nonobese group; CWG, corrected ideal body weight group; RWG, real body weight group; T0, T15, T30, T60, T120, and T240: baseline and 15, 30, 60, 120, and 240 min after magnesium sulfate administration. Two-wayrepeated-measures analysis of variance. The control group was not represented here because there were no changes in this group over time. |